Background
Left ventricular noncompaction (LVNC) is a distinct form of cardiomyopathy characterized by hypertrabeculation of the left ventricle. The LVNC phenotype may occur in isolation or with other cardiomyopathy phenotypes. Prognosis is incompletely characterized in children.
Methods and Results
Using diagnoses from the National Heart, Lung, and Blood Institute-funded Pediatric Cardiomyopathy Registry from 1990-2008, 155 of 3219 children (4.8%) had LVNC. Each LVNC patient was also classified as having an associated echocardiographically diagnosed cardiomyopathy phenotype (dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), isolated, or indeterminate). The time to death or transplant differed among the phenotypic groups (P = 0.035). Time to listing for cardiac transplantation significantly differed by phenotype (P < 0.001), as did time to transplantation (P = 0.015). The hazard ratio for death/transplant (with isolated LVNC as the reference group) was 4.26 (95% confidence interval [CI], 0.78 to 23.3) for HCM, 6.35 (95% CI, 1.52 to 26.6) for DCM, and 5.66 (95% CI, 1.04 to 30.9) for the indeterminate phenotype. Most events occurred in the first year after diagnosis.
Conclusion
LVNC is present in at least 5% of children with cardiomyopathy. The specific LVNC-associated cardiomyopathy phenotype predicts the risk of death/transplant and should inform clinical management.